Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy

Background: Immune-related adverse events are associated with efficacy of immune checkpoint inhibitors (ICIs). We hypothesize that immune-mediated thrombocytopenia could be a biomarker for response...